Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1

Author： Devico A.L. Fouts T.R. Shata M.T. Kamin-Lewis R. Lewis G.K. Hone D.M.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.15, 2002-05, pp. : 1968-1974

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prime-boost regime that combines Montanide ISA720 and Alhydrogel to induce antibodies against the HIV-1 derived multiepitope polypeptide TAB9

By Exposito Raya N. Quintana D. Carrazana Y. Gomez C.E. Duarte C.A.

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2646-2650

Elsevier

Access to resources Recommend Favorite

Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice

By Takahashi A. Ogasawara K. Matsuki N. Fujinaga K. Nakaya T. Ikuta K. Auwanit W. Honda M. Fukui Y. Sasazuki T. Iwabuchi K. Onoe K.

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1537-1543

Elsevier

Access to resources Recommend Favorite

Improvement of the systemic prime/oral boost strategy for systemic and local responses

By Lauterslager T.G.M. Stok W. Hilgers L.A.T.

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1391-1399

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

By Mantis N.J. Kozlowski

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3990-4001

Elsevier

Access to resources Recommend Favorite

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa

By Machado A.A. Baknabua M. Salaun D. de Mareuil J. Krciinak V. MacGregor R.R. Chermann J.-C. Hirsch I.

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite